LAZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LAZ is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading just above pivot support, but the trend is still technically weak, analyst sentiment is mixed-to-cautious, and there is no strong proprietary buy signal today. I would not treat this as an immediate buy for an impatient investor.
LAZ is in a short-term bearish setup. MACD histogram is negative at -0.242, RSI_6 is neutral at 47.116, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which points to a downtrend or at best a weak consolidation. The current pre-market price of 45.96 is close to pivot support at 45.802, with resistance at 47.662 and 48.811. That means upside needs a cleaner breakout before the chart improves. The stock trend data suggests some near-term bounce potential, but not enough to override the broader technical weakness.
Lazard is adding Brian McCabe from JPMorgan to lead its North America energy investment banking practice, which is a constructive business development move. AUM also rose to $275.4 billion as of April 30, 2026, up 6.3% month over month, showing healthy asset management momentum. Argus still keeps a Buy rating and expects stronger M&A activity in 2026 and 2027, which could help advisory revenue later.
Recent analyst commentary shows weaker-than-expected advisory activity due to delayed deal closures, and several firms lowered price targets. UBS is Neutral at $44, Morgan Stanley is Underweight at $53, Goldman is Sell at $45, and Keefe Bruyette moved to Market Perform. The market is also open in a broader risk-off context with the S&P 500 down 0.91% pre-market, which does not help near-term sentiment. There is no notable insider, hedge fund, or congress trading support in the data.
Latest quarterly financials were not provided clearly, so a full quarter-by-quarter assessment is limited. The most recent operating update available is the April 2026 AUM report, and that shows solid growth in assets under management, up 6.3% month over month to $275.4 billion. That is a positive signal for the asset management side of the business, but it does not fully offset the softer advisory revenue backdrop mentioned by analysts.
Analyst sentiment is mixed and has softened recently. Argus lowered its target to $52 from $63 but kept Buy, BofA earlier kept Buy with a lower target, while UBS is Neutral, Morgan Stanley is Underweight, Goldman is Sell, and Keefe Bruyette is Market Perform after cutting the target. Overall, Wall Street pros are split, but the recent direction of target changes has been downward, and the consensus tone is cautious rather than strongly bullish.
